MARKET

RVMD

RVMD

Revolution Medicines, Inc.
NASDAQ
151.56
-2.17
-1.41%
After Hours: 151.23 -0.33 -0.22% 19:24 05/22 EDT
OPEN
154.42
PREV CLOSE
153.73
HIGH
156.25
LOW
151.44
VOLUME
1.94M
TURNOVER
--
52 WEEK HIGH
156.25
52 WEEK LOW
34.00
MARKET CAP
32.22B
P/E (TTM)
-21.3666
1D
5D
1M
3M
1Y
5Y
1D
Bernstein Initiates Coverage of Revolution Medicines (RVMD) with Market Perform Recommendation
NASDAQ · 1d ago
Revolution Medicines Initiated at Market Perform by Bernstein
Dow Jones · 1d ago
Revolution Medicines Price Target Announced at $151.00/Share by Bernstein
Dow Jones · 1d ago
Bernstein Initiates Coverage On Revolution Medicines with Market Perform Rating, Announces Price Target of $151
Benzinga · 1d ago
Bernstein starts Revolution Medicines at Market Perform, says upside baked in
TipRanks · 2d ago
Revolution Medicines initiated with a Market Perform at Bernstein
TipRanks · 2d ago
Revolution Medicines Recasts RAS Story With Phase 3 Win And New Firepower
Simply Wall St · 3d ago
GraniteShares Files High-Octane 2X ETFs Tied To Nuclear, AI, Biotech Momentum Stocks
Benzinga · 4d ago
More
About RVMD
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMD stock methods without spending real money on the virtual paper trading platform.